Nefiracetam
- Level
- Commodity
- Parent
- 51143000
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51143016This classification denotes a neuroprotective agent with the molecular formula C14H18N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1JK12GX30N, chemically known as 2-oxo-1-pyrrolidineaceto-2,6-xylidide but generally known as nefiracetam, which bears US NIH Compound Identifier 71157. European Medicines Agency schedules Nefiracetam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09181MIG. The term NEFIRACETAM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 6, No, 3 1992, List 32). NEFIRACETAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nefiracetam under HS 29337900 and SITC 51561. As of Q4 2014, NEFIRACETAM remains the US FDA Preferred Term for this commodity. Nefiracetam bears US NLM identifiers UMLS ID C0165264 and NCI Concept Code C74325. SMILES: O=C1N(CCC1)CC(=O)NC1C(CCCC1C)C.
Same parent
Under 51143000 · 22Activities that produce or sell this
KBLI · 8Inherited from family 51140000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.